孟德尔随机化
非酒精性脂肪肝
疾病
医学
胰岛素抵抗
风险因素
脂肪肝
肥胖
2型糖尿病
内科学
糖尿病
重症监护医学
慢性肝病
生物信息学
内分泌学
生物
生物化学
肝硬化
遗传变异
基因
基因型
作者
Mei Li,Horng‐Dar Wang,Xiao‐Jing Zhang,Jingjing Cai,Hongliang Li
出处
期刊:Physiology
[American Physiological Society]
日期:2023-07-11
卷期号:38 (6): 255-265
被引量:20
标识
DOI:10.1152/physiol.00013.2023
摘要
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease worldwide that poses a significant threat to human health. Cardiovascular disease (CVD) is the leading cause of mortality in NAFLD patients. NAFLD and CVD share risk factors such as obesity, insulin resistance, and type 2 diabetes. However, whether NAFLD is a causal risk factor for CVD remains a matter of debate. This review summarizes the evidence from prospective clinical and Mendelian randomization studies that underscore the potential causal relationship between NAFLD and CVD. The mechanisms of NAFLD contributing to the development of CVD and the necessity of addressing CVD risk while managing NAFLD in clinical practice are also discussed.
科研通智能强力驱动
Strongly Powered by AbleSci AI